Michael E. Bertrand

Q: What Schools Are Affiliated With Michael E. Bertrand

Michael E. Bertrand is affiliated with the following schools: United States Military Academy, Duke University

Michael E. Bertrand's AcademicInfluence.com Rankings

Michael E. Bertrand

Medical

#3087

World Rank

#3541

Historical Rank

Surgery

#256

World Rank

#314

Historical Rank

Cardiology

#313

World Rank

#322

Historical Rank

medical Degrees

Michael E. Bertrand

Philosophy

#8901

World Rank

#12370

Historical Rank

Logic

#5911

World Rank

#7365

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Michael E. Bertrand's Degrees

Doctorate Medicine Stanford University

Why Is Michael E. Bertrand Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael E. Bertrand's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study (2001) (2577)
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). (2006) (1767)
Strategies for multivessel revascularization in patients with diabetes. (2012) (1569)
Bivalirudin for patients with acute coronary syndromes. (2006) (1122)
Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS). (2000) (1061)
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. (2002) (920)
Angiographic follow-up after placement of a self-expanding coronary-artery stent. (1991) (757)
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. (2001) (666)
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. (1998) (594)
Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. (1982) (516)
Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. (2000) (418)
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial (2007) (392)
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158 998 patients (2012) (386)
Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. (2002) (383)
Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (2011) (356)
A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. (2006) (339)
Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators. (1999) (339)
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. (2007) (304)
Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. (1997) (304)
Predictors of restenosis after coronary stent implantation. (1998) (299)
Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Report of The Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group. (1986) (271)
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. (2007) (267)
Restenosis after coronary angioplasty. (1995) (247)
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale. (2004) (246)
Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. (1998) (199)
Early Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Drug-Eluting and Bare Metal Stents: The Acute Catheterization and Urgent Intervention Triage Strategy Trial (2009) (197)
Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. (2009) (193)
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology* (2002) (187)
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. (2009) (176)
Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology. (1997) (172)
D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. (1997) (170)
Coronary angioscopic findings in the infarct-related vessel within 1 month of acute myocardial infarction: natural history and the effect of thrombolysis. (1998) (167)
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. (2005) (157)
ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. (2007) (152)
Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty. (1997) (142)
Long‐Term Oral Administration of L‐ Arginine Reduces Intimal Thickening and Enhances: Neoendothelium‐Dependent Acetylcholine‐Induced Relaxation After Arterial Injury (1994) (141)
Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. (2009) (141)
The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy. (2005) (137)
Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization. (2006) (136)
Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. (2002) (133)
Patency of Percutaneous Transluminal Coronary Angioplasty Sites at 6-Month Angiographic Follow-Up: A Key Determinant of Survival in Diabetics After Coronary Balloon Angioplasty (2001) (132)
Prognostic Modeling of Individual Patient Risk and Mortality Impact of Ischemic and Hemorrhagic Complications: Assessment From the Acute Catheterization and Urgent Intervention Triage Strategy Trial (2010) (131)
Choice of arterial access site and outcomes in patients with acute coronary syndromes managed with an early invasive strategy: the ACUITY trial. (2009) (131)
Relative Risk Analysis of Angiographic Predictors of Restenosis Within the Coronary Wallstent (1991) (129)
Acute coronary syndrome without ST elevation: implementation of new guidelines (2001) (124)
Mechanisms and prevention of restenosis: from experimental models to clinical practice. (1996) (124)
The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. (1997) (120)
Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem. (1997) (118)
Percutaneous coronary rotational angioplasty in humans: preliminary report. (1989) (112)
Quantitative angiographic follow-up of the coronary Wallstent in native vessels and bypass grafts (European experience--March 1986 to March 1990). (1992) (108)
The European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA). (1998) (106)
Impact of Different Platelet Glycoprotein IIb/IIIa Receptor Inhibitors Among Diabetic Patients Undergoing Percutaneous Coronary Intervention: Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-Year Follow-Up (2002) (103)
Percutaneous transluminal coronary rotary ablation with Rotablator (European experience). (1992) (103)
Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients. (1999) (103)
Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial (2001) (98)
Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. (2012) (97)
Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators. (2000) (96)
Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial (2000) (95)
Coronary arteriography in acute transmural myocardial infarction. (1979) (87)
Wiktor stent implantation in patients with restenosis following balloon angioplasty of a native coronary artery. (1992) (86)
Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Tr (2000) (85)
Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial). (2009) (85)
Provision of cardiovascular protection by ACE inhibitors:a review of recent trials (2004) (85)
Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. (2008) (83)
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. (2008) (83)
Impact of Clinical Syndrome Acuity on the Differential Response to 2 Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Coronary Stenting: The TARGET Trial* (2002) (83)
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text (2007) (82)
Detrimental effect of propranolol in patients with coronary arterial spasm countered by combination with diltiazem. (1983) (81)
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease. (2010) (81)
Additional improvement of stenosis geometry in human coronary arteries by stenting after balloon dilatation. (1988) (79)
Report of the Joint ISFC/WHO Task Force on Coronary Angioplasty. The International Society and Federation of Cardiology and the World Health Organization. (1988) (78)
The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. (2002) (77)
Discordant results of visual and quantitative estimates of stenosis severity before and after coronary angioplasty. (1993) (75)
Clinical and Angiographic Predictors of Short- and Long-Term Ischemic Events in Acute Coronary Syndromes: Results From the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) Trial (2010) (74)
Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1 (2009) (70)
Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management. (1996) (70)
Relation to restenosis after percutaneous transluminal coronary angioplasty to vasomotion of the dilated coronary arterial segment. (1989) (69)
Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. (2008) (68)
Proto-oncogene expression in rabbit aorta after wall injury. First marker of the cellular process leading to restenosis after angioplasty? (1992) (68)
Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodeling. (1999) (67)
Coronary sinus blood flow at rest and during isometric exercise in patients with aortic valve disease. Mechanism of angina pectoris in presence of normal coronary arteries. (1981) (67)
Automated 3D analysis of pre-procedural MDCT to predict annulus plane angulation and C-arm positioning: benefit on procedural outcome in patients referred for TAVR. (2013) (65)
Complete denervation of the heart (autotransplantation) for treatment of severe, refractory coronary spasm. (1981) (65)
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study (2006) (64)
Left ventricular systolic and diastolic function during acute coronary artery balloon occlusion in humans. (1988) (64)
Early and late assessment of stenosis geometry after coronary arterial stenting. (1988) (63)
Relation of coronary angioscopic findings at coronary angioplasty to angiographic restenosis. (1995) (63)
Comparative results of percutaneous transluminal coronary angioplasty in patients with dynamic versus fixed coronary stenosis. (1986) (63)
Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty. (1995) (62)
Response of Human Coronary Arteries to Serotonin After Injury by Coronary Angioplasty (1993) (62)
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. (2009) (62)
Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study). (2007) (58)
Effect of Ketanserin on Proximal and Distal Coronary Constrictor Responses to Intracoronary Infusion of Serotonin in Patients With Stable Angina, Patients With Variant Angina, and Control Patients (1992) (58)
Morphologic change in coronary artery stenosis with the Medtronic Wiktor stent: initial results from the core laboratory for quantitative angiography. (1991) (57)
Management Strategies for a Better Outcome in Unstable Coronary Artery Disease (1998) (56)
Local lesion-related factors and restenosis after coronary angioplasty. Evidence from a quantitative angiographic study in patients with unstable angina undergoing double-vessel angioplasty. (1995) (54)
Neointimal thickening after balloon denudation is enhanced by aldosterone and inhibited by spironolactone, and aldosterone antagonist. (1995) (53)
Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire Transluminale. (1997) (53)
Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries. (1997) (53)
The provocation of coronary arterial spasm in patients with recent transmural myocardial infarction. (1983) (53)
The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial. (2007) (52)
Treatment of Prinzmetal's variant angina. Role of medical treatment with nifedipine and surgical coronary revascularization combined with plexectomy. (1981) (52)
Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial (2007) (50)
Clinical characteristics and angiographic follow-up of patients undergoing early or late repeat dilation for a first restenosis. (1992) (49)
The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. (2001) (48)
Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk. (2006) (48)
ACE Inhibition and Endothelial Function: Main Findings of PERFECT, a Sub-Study of the EUROPA Trial (2007) (48)
The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. (2014) (47)
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals (2011) (47)
Effects of coronary stenting on restenosis and occlusion after angioplasty of the culprit vessel in patients with recent myocardial infarction. (1997) (46)
Impact of renin-angiotensin system inhibitors on mortality and major cardiovascular endpoints in hypertension: A number-needed-to-treat analysis. (2015) (45)
Basic fibroblast growth factor restores endothelium-dependent responses after balloon injury of rabbit arteries. (1996) (45)
Contribution of dynamic vascular wall thickening to luminal narrowing during coronary arterial vasomotion. (1983) (44)
Angiographic predictors of recurrence of restenosis after Wiktor stent implantation in native coronary arteries. (1993) (42)
Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA study. (2010) (42)
The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry. (2012) (41)
Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis. (1995) (40)
Morphological changes after percutaneous transluminal coronary angioplasty of unstable plaques. Insights from serial angioscopic follow-up. (1996) (36)
Treatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization. (2006) (36)
ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: Pertinent (2007) (35)
Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. (2011) (34)
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial (2011) (34)
Angiographically documented late reocclusion after successful coronary angioplasty of an infarct-related lesion is a powerful predictor of long-term mortality. (1999) (34)
Coronary Hemodynamics Following Intravenous or Intracoronary Injection of Diltiazem in Man (1982) (34)
Apical hypertrophic cardiomyopathy: clinical and metabolic studies. (1983) (33)
Two‐pronged antiplatelet therapy with aspirin and ticlopidine without systemic anticoagulation: an alternative therapeutic strategy after bailout stent implantation (1995) (32)
Effects of stenting of recent or chronic coronary occlusions on late vessel patency and left ventricular function. (1997) (32)
Angiopeptin inhibits oncogene induction in rabbit aorta after balloon denudation. (1994) (31)
Clinical results of coronary excimer laser angioplasty: report from the European Coronary Excimer Laser Angioplasty Registry. (1994) (31)
Cineangiographic assessment of left ventricular function in the acute phase of transmural myocardial infarction. (1979) (31)
Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease. (2013) (31)
Secondary Prevention of Coronary Disease with ACE Inhibition-does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA? (2009) (30)
PERCUTANEOUS LASER ANGIOPLASTY WITH SAPPHIRE TIP (1987) (29)
Recoil following Wiktor stent implantation for restenotic lesions of coronary arteries. (1994) (29)
Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site. A quantitative angiographic study in consecutive patients undergoing a third angioplasty procedure for a second restenosis. (1993) (29)
Efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery disease. (2007) (28)
Multi-center registry of percutaneous coronary rotational ablation using the rotablator (1991) (27)
Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data. (2011) (26)
The impact of the coronary collateral circulation on outcomes in patients with acute coronary syndromes: results from the ACUITY trial (2013) (26)
The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease (2009) (26)
Percutaneous aspiration of a coronary thrombus. (1989) (26)
Paraoxonase polymorphism (Gln192Arg) as a determinant of the response of human coronary arteries to serotonin. (2000) (25)
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up. (2005) (25)
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT study. (2009) (24)
NO synthesis is involved in structural and functional effects of ACE inhibitors in injured arteries. (1996) (24)
Potassium channel activators in vasospastic angina. (1993) (23)
Repeat percutaneous coronary angioplasty; clinical and angiographic follow-up in patients with stable or unstable angina pectoris. (1993) (23)
The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials (2017) (23)
Predictors of Outcomes in Medically Treated Patients With Acute Coronary Syndromes After Angiographic Triage: An Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Substudy (2010) (22)
Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictors of restenosis after coronary angioplasty. (1998) (22)
Prevention of Coronary Spasm by Nicorandil: Comparison with Nifedipine (1992) (21)
A prospective "oversizing" strategy of the Edwards SAPIEN bioprosthesis: results and impact on aortic regurgitation. (2013) (21)
When and how to discontinue antiplatelet therapy (2008) (20)
Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function. (2007) (20)
Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis. (2015) (20)
Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary grafts (the ACUITY trial investigators). (2010) (20)
bFGF restores endothelium-dependent responses of hypercholesterolemic rabbit thoracic aorta. (1997) (19)
Clinical and angiographic results with the ACS MULTI-LINK DUET™ Coronary Stent System – the DUET Study (2000) (19)
Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarction. (2015) (19)
Percutaneous transluminal coronary angioplasty in patients with spasm superimposed on atherosclerotic narrowing. (1987) (18)
Angiotensin converting enzyme inhibition prevents proto‐oncogene expression in the vascular wall after injury (1995) (18)
Left ventricular compliance in acute transmural myocardial infarction in man. (1978) (18)
Frequency of provocated coronary artery spasm in 273 patients with chest pain (1980) (18)
Effectiveness of intravenous streptokinase on infarct size and left ventricular function in acute myocardial infarction, prospective and randomized study (1987) (18)
Exercise‐Induced ST‐Segment Depression in Patients Without Restenosis After Coronary Angioplasty: Relation to Preprocedural Impaired Left Ventricular Function (1994) (17)
Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trial (2007) (17)
Enhanced efficacy of computerized exercise test by multivariate analysis for the diagnosis of coronary artery disease. A study of 558 men without previous myocardial infarction. (1987) (17)
Treatment of spasm of the coronary artery with nifedipine. (1980) (17)
Intramural injection of biodegradable microspheres as a local drug-delivery system to inhibit neointimal thickening in a rabbit model of balloon angioplasty. (1998) (16)
Six-month quantitative angiographic follow-up of < 50% diameter stenoses dilated during multilesion percutaneous transluminal coronary angioplasty. (1993) (16)
ACE inhibition accelerates endothelial regrowth in vivo: a possible explanation for the benefit observed with ACE inhibitors following arterial injury. (1997) (16)
Early beneficial effect of streptokinase on left ventricular function in acute myocardial infarction. (1991) (15)
Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy. (2010) (15)
Prognostic significance of silent myocardial ischaemia during maximal exercise testing after a first acute myocardial infarction. (1993) (15)
ACE polymorphism, a genetic predictor of occlusion after coronary angioplasty. (1996) (14)
Maximal exercise in normal subjects: changes in coronary sinus blood flow, contractility and myocardial extraction of FFA and lactate. (1977) (14)
Handbook of Cardiovascular Interventions (1996) (14)
Drug‐eluting stents: trading restenosis for thrombosis? (2007) (14)
L-arginine and L-NAME have no effects on the reendothelialization process after arterial balloon injury. (1999) (13)
741-2 Full Antiplatelet Therapy without Anticoagulation After Coronary Stenting (1995) (13)
Heparin does not inhibit oncogene induction in rabbit aorta following balloon denudation. (1993) (13)
[Long-term prognosis of coronary artery spasm]. (1990) (12)
Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model (2016) (12)
[Report of the joint meeting of the International Society and Federation of Cardiology and the World Health Organization Task Force on Coronary Angioplasty]. (1989) (12)
Late is perhaps not ... too late for primary PCI in acute myocardial infarction. (2002) (12)
Triple Combination Therapy for Global Cardiovascular Risk: Atorvastatin, Perindopril, and Amlodipine (2016) (11)
Prevention of restenosis future directions. (1997) (11)
Rotational ablation using the rotablator for angiographically unfavorable lesions (1991) (11)
Quality of life after coronary angioplasty or bypass surgery. (1999) (11)
Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trial (2011) (11)
Protective Effects of Basic Fibroblast Growth Factor in Early Atherosclerosis (2004) (11)
Cytomegalovirus infection and coronary restenosis. (1999) (11)
Use of provocative testing in angina pectoris. (1980) (10)
Hypersensitivity of human coronary segments to ergonovine 6 months after injury by coronary angioplasty: a quantitative angiographic study in consecutive patients undergoing single-vessel angioplasty. (1996) (10)
Percutaneous coronary rotary ablation. (1990) (9)
Coronary collaterals and left ventricular function early after acute transmural myocardial infarction. (1982) (9)
Effect of balloon inflation in angiographically normal coronary segments during coronary angioscopy: a quantitative angiographic study. (1994) (9)
Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trial. (2009) (9)
[Electron microscopic comparison of the antithrombotic potential of 2 low osmolality iodine contrast media in percutaneous transluminal coronary angioplasty]. (1994) (9)
ACE gene polymorphism and coronary restenosis. (1999) (8)
[Hemodynamic and coronary effects of isosorbide dinitrate: comparison of intravenous and intracoronary injection]. (1982) (8)
A prospective, randomized trial of bivaliruclin in acute coronary syndromes: One year results from the ACUITY Trial (2007) (8)
Prognostic value of angiographic lesion complexity in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the acute catheterization and urgent intervention triage strategy trial). (2014) (8)
Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - results from EUROPA. (2015) (8)
Erratum to "Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation" (Eur Heart J (2002) 23, 1809-1840) (2003) (8)
Dose‐Response Curve of Angiographically Smooth Human Epicardial Vessel Segments to Intracoronary Injections of Isosorbide Dinitrate (1992) (8)
[Abnormal origin of the left circumflex coronary artery: clinical, angiographic and prognostic aspects. Apropos of 30 cases]. (1992) (7)
Incremental cost-effectiveness of early and long-term clopidogrel in patients undergoing percutaneous coronary infarction in the CURE trial: The PCI-CURE economic analysis (2003) (6)
Chapter 1: Pressures (1985) (6)
951-73 Combined Antiplatelet Therapy without Anticoagulation: An Effective Alternative to Prevent Subacute Thrombosis After Coronary Stenting?A 3 Month Follow-up (1995) (6)
[Treatment of first restenosis by recurrent angioplasty. Immediate results and angiographic follow-up after 6 months]. (1992) (6)
Cardiogenic shock: is there light at the end of the tunnel? (2003) (6)
In Memoriam Hans Peter Krayenbϋhl (1933–1993) (1994) (6)
Abrupt closure following rotational ablation with the rotablator — Short term clinical follow up (1991) (6)
[Incidence of induced coronary artery spasm in recent acute transmural myocardial infarction]. (1983) (5)
[Coronary artery spasm. Apropos of 165 cases]. (1983) (5)
Myocardial metabolic alterations after contrast angiography (1983) (5)
Combined antiplatelet therapy without anticoagulation after stent implantation; the Ticlopidine Aspirin Stent Evaluation (TASTE) study (1996) (5)
[From the angiogenic response to ischemia to the validation of the concept of "therapeutic angiogenesis"]. (1998) (4)
Clinical and angiographic results with the ACS MULTI-LINK DUET trade mark Coronary Stent System - the DUET Study. (2000) (4)
OUTCOMES OF PATIENTS WITH ACUTE CORONARY SYNDROMES AND PRIOR CORONARY ARTERY BYPASS GRAFTING: ANALYSIS FROM THE ACUITY TRIAL (2010) (4)
[Vasomotor activity and coronary insufficiency]. (1991) (4)
Restenosis after coronary angioplasty for rapidly progressive coronary stenosis. (1996) (4)
Relative prognostic value of clinical, exercise, and angiographic data after a first myocardial infarction (1993) (4)
Reuse of catheters in the catheterization laboratory (1999) (4)
[Myocardial infarction in people under 30 years of age]. (1982) (4)
Morphological changes of coronary stenosis after repeated balloon angioplasties: a quantitative angiographic study. (1991) (4)
[Restenosis after angioplasty]. (1999) (4)
Provocative test in recent myocardial infarction. (1986) (4)
What is the role of the coronary circulation in congestive heart failure? (1983) (4)
Comparison of betablockers and calcium antagonists in the treatment of patients with coronary artery spasm (1982) (3)
Triple antiplatelet treatment in patients presenting with non-ST-segment elevation acute coronary syndromes (2006) (3)
What are the current risks of cardiac catheterization? (2011) (3)
Effect of intracoronary nicardipine on methylergonovine-induced coronary artery spasm in patients with variant angina. (1989) (3)
Management of unstable angina : an evolving field : proceedings of a symposium held at the XIXth Congress of the European Society of Cardiology, Stockholm, Sweden, August 1997 (1998) (3)
Nature of coronary disease in patients with insulin resistance and its impact on revascularization strategies (2005) (3)
Peripheral laser angioplasty with sapphire tip. (1991) (3)
IMPACT OF ANTIHYPERTENSIVE TREATMENT ON MORTALITY: A LATE-BREAK ANALYSIS OF RECENT CLINICAL TRIALS IN HYPERTENSION: PP.37.495 (2010) (3)
Abnormal diffuse coronary vasomotion. (1989) (3)
Cardioprotective effect of intracoronary nifedipine during percutaneous transluminal coronary angioplasty. A French double-blind cross-over multicentre study. (1993) (3)
[Acute hemodynamic effects of betaxolol in uncomplicated arterial hypertension in young persons]. (1982) (3)
[Value of negative U waves in coronary artery spasm]. (1990) (3)
Abstract 18906: Combining Perindopril With a Calcium Channel Blocker and a Lipid Lowering Agent Significantly Decreases Mortality: A Subgroup Analysis of Europa (2013) (3)
Non-ST-segment elevation acute coronary syndromes: an algorithm for decision. (2007) (3)
In MemoriamAttilio Reale 1924–1991 (1991) (3)
The need for a central registration of procedures: the French experience. (1987) (3)
Prognostic value of changes in R-wave amplitude during exercise testing after a first acute myocardial infarction. (1992) (3)
[Coronary artery spasm]. (1988) (3)
Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy). (2014) (3)
Procedural variables associated with eventual long term angiographic success in patients with recurrent restenosis. (1991) (3)
Comments of the Editors (1985) (2)
[Transluminal coronary angioplasty: immediate and short-term results. Apropos of 302 dilated vessels]. (1986) (2)
[Predictive factors of primary success after coronary angioplasty. Qualitative and quantitative angiography of 3679 coronary stenosis before and after dilatation]. (1994) (2)
Mechanical recanalization of coronary arteries (1991) (2)
Rotational atherectomy — An overview (1994) (2)
Frequency of provoked coronary arterial spasm in patients with recent transmural myocardial infarction (1981) (2)
How can the European Society of Cardiology ensure compliance with ethical standards? (2016) (2)
[Pulsus alternans: alternation of relaxation parameters]. (1984) (2)
Perindopril/amlodipine combination: an optimal synergy for cardiovascular protection (2009) (2)
[Guidelines for the training of practitioners in coronary angiography and angioplasty, the organization and equipment of centres of coronary angiography and transluminal angioplasty]. (1991) (2)
[Endothelial dysfunction in cardiovascular diseases: therapeutic implications after coronary angioplasty]. (1997) (2)
[A new method of laser angioplasty by contact sapphire: preliminary results. Apropos of 20 cases]. (1988) (2)
Frequency and role of coronary artery spasm in heart disease. (1983) (2)
Management of unstable angina pectoris with maximal medical treatment (combination of intravenous nitrates, beta-blockers, calcium antagonists and heparin). (1985) (2)
Provoked Coronary Arterial Spasm (1981) (2)
Coronary angioscopy — An inner view (1994) (2)
Abstract 5066: The Treatment Effect of Perindopril is Consistent in All Patients with Vascular Disease or High Risk of Vascular Disease: A Combined Analysis of Three Perindopril Trials (2008) (2)
Impact of anticoagulation regimen prior to revascularization in patients with non‐ST‐segment elevation acute coronary syndromes: The ACUITY trial (2016) (2)
[Measurement of the diameter of coronary arteries and coronary stenoses. Presentation of 2 methods]. (1985) (2)
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutancous coronary intervention: One year results from the randomized ACUITY trial (2007) (2)
[Treatment of a severe coronary artery spasm, refractory to complete denervation of the heart (autotransplantation)]. (1982) (2)
[Value of the computerized analysis of ST segment depression during exercise without myocardial infarction. Apropos of 807 cases]. (1986) (2)
Abstracts - ACCIS2002 (angiography & interventional cardiology)Impact of clinical syndrome acuity on the differential response to two glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET trial (2002) (2)
Long-Term Follow-up After Peripheral and Coronary Angioplasty in Patients Undergoing Both Types of Procedure (1994) (2)
[Long-term prognosis after myocardial infarction. Value of exercise test compared to clinical features and coronarography]. (1991) (1)
934-28 Sensitivity and Specificity of Angiographic Markers for Thrombus: A Prospective Comparison with Angioscopy (1995) (1)
[Recanalization of complete coronary occlusions followed by STENT implantation. An angiographic study after 6 months]. (1997) (1)
[Coronary endovascular prostheses (stents) in the treatment of imminent or acute occlusion as a complication of coronary angioplasty]. (1995) (1)
Benefit of clopidogrel in patients undergoing percutaneous coronary intervention in the CURE trial receiving and not receiving an intracoronary stent (2003) (1)
[Percutaneous coronary angioscopy: 200 observations in 100 candidates for angioplasty]. (1995) (1)
Integrative Acarology: Proceedings of the sixth Congress of the European Association of Acarologists (2008) (1)
Coronary arterial angiographic findings during transient myocardial ischemia. (1986) (1)
[Metabolism of the myocardium in man]. (1974) (1)
[Complications of transluminal coronary angioplasty. A multicenter French study (1983)]. (1985) (1)
Identification of intervention patients at increased risk. (1995) (1)
Evaluation Of Optical Property And Thermal Behaviour Of A Sapphire Tip Catheter During ND:YAG Laser Delivery (1988) (1)
[Cross-over double-blind study of verapamil versus diltiazem in effort myocardial ischemia]. (1989) (1)
[Coronary artery spasms]. (1977) (1)
760-4 Initial Multicenter Experience with Therapeutic Ultrasonic Coronary Angioplasty in Patients (1995) (1)
PP.07.30: PERINDOPRIL AND BETA-BLOCKER FOR THE PREVENTION OF CARDIAC EVENTS AND MORTALITY IN STABLE CAD PATIENTS A EUROPA SUBANALYSIS (2015) (1)
Abstract 3303: Safety and Efficacy of Bivalirudin in Patients with non-ST Elevation Acute Coronary Syndromes Undergoing Medical Management: Results from the Randomized ACUITY Trial (2006) (1)
[Stenosis of the common trunk of the left coronary artery: an unusual complication of percutaneous coronary angioplasty]. (1992) (1)
Long term risk/benefit of PTCA of infarct related vessel (1991) (1)
Acute coronary syndromes : a handbook for clinical practice (2006) (1)
[Coronary artery dilatation induced by isosorbide dinitrate injection (author's transl)]. (1982) (1)
Management strategies in unstable coronary artery disease—Current problems and future directions (1999) (1)
[Congenital abnormalities in the coronary arteries (author's transl)]. (1976) (1)
[Restenosis after coronary angioplasty. Contribution of experimental models]. (1993) (1)
Abstract selection for the XVth Congress of the European Society of Cardiology, 29 August–2 September 1993, Nice, France (1993) (1)
Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy). (2010) (1)
Timing and risk factors for enzymatic myocardial infarctions in patients undergoing percutaneous intervention: Insights from TARGET (2003) (1)
[Continuous electrocardiographic recording using the Holter method in 20 patients presenting with coronary spasm. Study of 277 electric crises]. (1983) (1)
[Permanent atrial standstill and its relationship with auricular disease (author's transl)]. (1979) (1)
Research forum abstractPoster session I: Cardiology—Moderator: Gregory J. Fermann, MD95: Early, Upstream, and Consistent Antithrombotic Therapy in High Risk Non-ST-Elevation ACS: Should Bivalirudin Be Initiated in the ED Prior to Coronary Angiography? (2006) (1)
[Congenital aneurysm of the coronary arteries. Apropos of 2 cases]. (1988) (1)
The Wallstent Experience: 1986–1990 (1993) (1)
DETERMINANTS OF COLLATERAL CIRCULATION IN PATIENTS WITH DOCUMENTED CORONARY OCCLUSION: THE CASE FOR GENDER AND SMOKING (2010) (1)
The D Allele of the Angiotensin I Converting Enzyme Is Associated With Diffuse In-stent Restenosis (1998) (1)
[Hemodynamic and coronary effects of methylergometrin]. (1983) (1)
Quantitative assessment of the residual stenosis after percutaneous transluminal cororonary rotary ablation: European Experience (1993) (1)
[Multicenter epidemiological survey of primary myocardiopathies. Apropos of 380 cases]. (1979) (1)
Proposal for a Randomized Study of Surgical Vs Medical Treatment in Patients with Asymptomatic Coronary Artery Disease (1984) (1)
Chronic kidney disease is associated with increased mortality, bleeding, and ischemic events in moderate and high-risk patients with acute coronary syndromes: An ACUITY substudy (2007) (1)
Six month clinical and angiographic follow-up of stenting without anticoagulation: The Ticlopidine Aspirin Stent Evaluation (TASTE) study (1996) (1)
[Coronary angioplasty of multivessel coronary diseases. Apropos of 1664 procedures. Immediate results and results following 6 months]. (1992) (1)
[Value of coronarography in the pre-operatory assessment of aortic valvulopathies. A description of ninety cases (author's transl)]. (1977) (0)
Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictor of restenosis after coronary angioplasty (1996) (0)
945-118 Validation of a Simple Exercise-Test Based Method for Early Identification of Multivessel Coronary Disease After Acute Myocardial Infarction (1995) (0)
Wednesday, 29 August 2012 (2012) (0)
[The advantage of hemodynamic investigations in the treatment of arterial hypertensions (author's transl)]. (1978) (0)
Drug eluting stents in patients with acute coronary syndromes undergoing percutaneous coronary intervention: The ACUITY trial (2006) (0)
Comparison of heparin plus IIb/IIIa inhibition versus bivalirudin with or without IIb/IIIa inhibition in patients with acute coronary syndromes undergoing percutaneous coronary intervention: The ACUITY trial (2006) (0)
Non‐ST‐Segment Elevation Coronary Syndromes: European Society of Cardiology Guidelines (2009) (0)
[Response of coronary arteries to the intracoronary injection of isosorbide dinitrate. Dose-response curve]. (1992) (0)
Coronary Stenting : The Full Anticoagulation Versus Randomized Multicenter Comparison of Conventional Anticoagulation Versus Antiplatelet (1998) (0)
Immediate and long-term clinical and angiographic results following WiktorTM stent implantation in patients with documented restenosis of a native coronary artery lesion following prior balloon angioplasty (1993) (0)
Modifications in Coronary Flow After Injection of Contrast Media (1982) (0)
Left ventricular function during acute coronary artery balloon occlusion in humans (1990) (0)
Abstract selection for the Joint XIIth World Congress of Cardiology and XVIth Congress of the European Society of Cardiology, September 10–September 14,1994, Berlin, Germany (1994) (0)
[Hemodynamic and coronarographic evaluation for identification of high risk patients following myocardial infarction]. (1985) (0)
Impact of Bivalirudin Monotherapy on 30-day Outcomes in Patients with Acute Coronary Syndromes and Complex Coronary Stenoses Undergoing Percutaneous Coronary Intervention (2009) (0)
968-30 Does Insertion/Deletion Polymorphism of the Angiotensin Converting Enzyme Influence the Occurrence of Restenosis After Percutaneous Transluminal Coronary Angioplasty? (1995) (0)
Reversing myocardial stunning with early streptokinase treatment (1991) (0)
EFFECT OF ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS ON ALL-CAUSE MORTALITY IN HYPERTENSION TRIALS: 3A.03 (2011) (0)
XIIIth Congress of the European Society of Cardiology. 18-22 August 1991, Amsterdam, The Netherlands. (1991) (0)
[Interest of indices of left ventricular function in assessment of coronary heart disease (author's transl)]. (1980) (0)
Effect of Pravastatin on Angiographic Restenosis After Coronary Balloon Angioplasty fn1fn1This study was supported by a grant from Bristol Myers Squibb Laboratories, Paris. (1997) (0)
Coronary arterial spasm in acute myocardial infarction. (1978) (0)
[The indications for surgery in valvular aortic stenosis]. (1975) (0)
Clopidogrel pretreatment versus clopidogrel exposure prior to PCI in the ACUITY Trial: Does it really matter? (2007) (0)
Variant angina pectoris and sympathetic nervous system function. (1980) (0)
[Early detection of myocardial alterations in mitral insufficiency with the angiotensin test]. (1982) (0)
[Long-term effects of transluminal coronary angioplasty. French multicenter study]. (1985) (0)
A CD reatment decisions in stable coronary artery disease : nsights from the Euro Heart Survey on Coronary evascularization (2006) (0)
Optimal Antithrombotic Therapy (2009) (0)
[Calcification of the left auricle. A description of six cases (author's transl)]. (1976) (0)
4. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY IN ACUTE MYOCARDIAL INFARCTION (1989) (0)
Ace inhibition with perindopril and markers of atherosclerosis and thrombosis: Results of the pertinent study (2007) (0)
[Should moderate coronary stenosis be dilated in patients with multi-vessel disease?]. (1993) (0)
Restenosis — narrowing in on the cause and cure (2004) (0)
Abstract selection for the XlVth Congress of the European Society of Cardiology, 30 August–3 September 1992, Barcelona, Spain (1992) (0)
Different propensity of coronary restenosis: Comparison between cutting balloon, conventional balloon and atherectomy (1996) (0)
[Other techniques of arterial recanalization]. (1990) (0)
Variant angina piectoris and sympathetic nervous system function (1980) (0)
Laser Angioplasty Using a Sapphire-Tip Catheter: Preliminary Clinical Trial (1990) (0)
[Endothelial dysfunction in cardiovascular pathology]. (1997) (0)
[Opening ceremonies of the European session of the French Society of Cardiology (15 January 1998)]. (1998) (0)
[Myocardial revascularization in silent myocardial ischemia]. (1993) (0)
[Spasm of the coronary arteries : the present, the future...]. (1982) (0)
Is early invasive treatment superior to selectively invasive treatment in patients with acute coronary syndromes? (2006) (0)
[The role of coronary artery spasm in unstable angina pectoris]. (1983) (0)
Abstract (2007) (0)
[Report on the meeting of the International Society and Federation of Cardiology and World Health Organization: task-force on coronary angioplasty]. (1988) (0)
[Coronary lesions and left ventricular function in the acute phase of myocardial infarction]. (1987) (0)
[Calcium, calcium antagonists and coronary insufficiency]. (1988) (0)
NATURAL HISTORY OF INFARCT-RELATED LESIONS. AUTHORS' REPLY (1998) (0)
IMPACT OF ANTICOAGULATION REGIMEN IN PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROMES UNDERGOING AN EARLY INVASIVE STRATEGY INDEPENDENT OF REVASCULARIZATION: THE ACUITY TRIAL (2010) (0)
[Angiography of the left ventricle]. (1993) (0)
[Coronary arteriography in recent myocardial infarct]. (1977) (0)
[Double-blind study against placebo of the efficacy and tolerance of labetalol 400 mg/day in moderate arterial essential hypertension in the adult]. (1982) (0)
[Interventricular communication secondary to a perforating wound of the heart. A description of two cases operated on successfully (author's transl)]. (1977) (0)
Poor Correlation Between Non Invasive Cardiac Imaging and Fractional Flow Reserve (FFR) in Patients With Multivessel Coronary Artery Disease (2013) (0)
Abstract 2001: Clinical and Angiographic Predictors of 30-Day and One-Year Ischemic Cardiac Events in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An ACUITY Substudy (2008) (0)
[OP.4A.11] THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE AND HYPERTENSION (2017) (0)
Clinical Aspects of Atherosclerosis. Role of Coronary Artery Spasm (1983) (0)
[Evaluation of the anesthetic risk in patients with coronary disease prior to non-cardiac surgery]. (1993) (0)
[Coronary artery spasm (author's transl)]. (1979) (0)
[Strategy of the treatment of vasospastic angina pectoris]. (1983) (0)
Preventing cardiac events in unstable angina : New data with diltiazem. Discussion (1996) (0)
[PP.35.22]: LIFELONG BENEFITS OF ACE INHIBITORS ON CARDIOVASCULAR EVENTS AND MORTALITY IN HYPERTENSIVE PATIENTS (2015) (0)
[Report on coronary angioplasty by the joint working group of the International Society and Federation of Cardiology and the World Health Organization]. (1988) (0)
[Coronary angioplasty in diabetic patients. Analysis of the problems to improve results]. (1999) (0)
Long-term outcomes of patients with acute coronary syndromes and chronic renal insufficiency undergoing percutaneous coronary intervention and being treated with bivalirudin vs heparin plus a glycoprotein IIb/IIIa inhibitor: Results from the randomized ACUITY Trial (2007) (0)
Left ventricular cineangiography during coronary angioplasty (1986) (0)
Les cardiomyopathies non obstructives (1987) (0)
[Ischemic cardiomyopathies]. (1985) (0)
[Is preventive aorto-coronary by pass justified? (author's transl)]. (1977) (0)
Current guidelines for acute coronary syndromes (2012) (0)
[Probability of coronary lesions evaluated by the discriminant analysis of clinical and ergometric parameters]. (1987) (0)
[Coronary angioplasty immediately after intracoronary thrombolysis during the acute phase of myocardial infarction]. (1984) (0)
Late vessel occlusion is a frequent mode of restenosis after balloon angioplasty in diabetic patients (1998) (0)
Left Ventricular Systolic and Diastolic Function Immediately After Acute Coronary Artery Occlusion (1991) (0)
[Address of the outgoing President]. (1998) (0)
[Prevention of myocardial ischemia during exercise 8 hours after use of transdermal nitrate derivatives]. (1986) (0)
New evidence for angiotensin-converting enzyme inhibition in stroke, cardiac and renal patients: the cardiological approach (2003) (0)
[Nitrate derivatives and coronary vasomotricity]. (1992) (0)
[Reality, frequency and treatment of coronary artery spasm]. (1982) (0)
[Spasm in coronary arteries]. (1981) (0)
[PP.13.01] THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE (2016) (0)
Predictors of Restenosis Within the Coronary Wallstent (2005) (0)
Oncogenes after Angioplasty (1997) (0)
coronary syndromes: results from the ACUITY trial The impact of the coronary collateral circulation on outcomes in patients with acute (2015) (0)
[Coronary angioscopy]. (1997) (0)
[Extreme lability of the electrocardiogram in an allergic dysneurotonic patient]. (1961) (0)
3 Current Therapeutic Needs in Hypertensive Patients with Hypercholesterolemia or Stable Coronary Artery Disease ( CAD ) (2016) (0)
[Predictive value of exercise-induced ST depression in the diagnosis of restenosis after coronary angioplasty]. (1989) (0)
Multifocal peripheral and coronary angioplasties. (1993) (0)
Acknowledgement Letter CDI 32 (12) (2012) (0)
Coronary Angiography, Angioscopy, and Intravascular Ultrasound in Non‐ST‐Segment Elevation Acute Coronary Syndromes (2009) (0)
[Representative observations of therapies in arterial hypertension]. (2001) (0)
[And after myocardial infarction?]. (1995) (0)
[Evaluation of left ventricular performance by unidimensional echocardiography (author's transl)]. (1980) (0)
[Comparative study of short and medium-term results of angioplasty and bypass in severe or unstable angina pectoris caused by isolated stenosis of the anterior interventricular branch]. (1986) (0)
Abstract 3302: Outcomes in Elderly Patients Treated with Bivalirudin Monotherapy Versus Glycoprotein IIb/IIIa Inhibitors with Heparin or LMWH: Results from the Randomized ACUITY Trial (2006) (0)
Abstract 4589: Anti-thrombotic Strategies in Patients with Elevated Biomarkers Undergoing PCI: Results from the ACUITY Trial (2008) (0)
940-72 Effect of Late Coronary Angioplasty of an Infarct-related Vessel on Left Ventricular Function (1995) (0)
The shorter the better? (2007) (0)
Elective PCI anticoagulation therapy / thrombin inhibitors (2009) (0)
Percutaneous Transluminal Coronary Angioplasty in Acute Myocardial Infarction (1989) (0)
[Non-obstructive hypertrophic myocardiopathy. Apropos of 5 cases]. (1980) (0)
Clinical and Angiographic Predictors of Death or Myocardial Infarction in Diabetics with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An ACUITY Subanalysis (2009) (0)
Calcium antagonists and coronary artery spasm (1984) (0)
Comparison of catheterization lab initiated abciximab and double-bolus eptifibatide during percutaneous coronary intervention in acute coronary syndromes: an ACUITY substudy (2007) (0)
Reply: MDCT in TAVR for better implant angle and outcomes. (2013) (0)
[Relation between progression of atherosclerosis and the phenomenon of restenosis after coronary angioplasty]. (1996) (0)
[Functional studies of the left ventricle with catheterization and angiography]. (1982) (0)
Outcomes of bivalirudin in moderate and high risk patients with acute coronary syndromes and renal insufficiency: An ACUITY substudy (2007) (0)
[Reproducibility of the exercise test and coronary vasomotor tonus]. (1988) (0)
[Detection of coronary artery spasm by the methylergometrin test. Technic. Results. Indications]. (1979) (0)
Association ofangiotensin converting enzymeand angiotensin IItype1receptor genotypes withleft ventricular function andmassinpatients with angiographically normal coronary arteries (1997) (0)
Serotonin After Injury by Coronary Angioplasty (2005) (0)
Angiographic findings in the of the acute catheterization and urgent intervention triage strategY (ACUITY) trial (2006) (0)
Beneficial effect of streptokinase in the first 4 days after acute myocardial infarction (1991) (0)
[Vasodilators for intracoronary use]. (1988) (0)
[Development and evaluation of a laser catheter with tip fiberoptic for coronary angioplasty]. (1991) (0)
Secondary Prevention after Acute Episode of Patients Presenting with Nonpersistent ST‐Segment Elevation (2009) (0)
242 Cardiovascular Benefits Of Perindopril In Coronary Artery Disease Patients With Hypertension. New Findings From The Europa Study According Jnc-7 Definition Of Hypertension (2010) (0)
[Coronary vasomotor activity in man. Description of a method of quantification and normal values]. (1986) (0)
[20 years of cardiovascular epidemiology. The clinician's viewpoint]. (1996) (0)
[Prinzmetal's angina pectoris: 20 years later]. (1979) (0)
Abstract 2564: Predictors of Early Stent Thrombosis in Patients with Acute Coronary Syndromes in the Drug-Eluting Stent Era: Analysis from the ACUITY trial (2007) (0)
[Coronary arteriography during the acute phase of myocardial infarction (author's transl)]. (1978) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael E. Bertrand?

Michael E. Bertrand is affiliated with the following schools:

Michael E. Bertrand's Academic­Influence.com Rankings

Michael E. Bertrand's Degrees

Why Is Michael E. Bertrand Influential?

Michael E. Bertrand's Published Works

Published Works

What Schools Are Affiliated With Michael E. Bertrand?

Michael E. Bertrand's AcademicInfluence.com Rankings